Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy

Christina K. Augustine, Hiroaki Toshimitsu, Sin Ho Jung, Patricia A. Zipfel, Jin S. Yoo, Yasunori Yoshimoto, M. Angelica Selim, James Burchette, Georgia M. Beasley, Nicole McMahon, James Padussis, Scott K. Pruitt, Francis Ali-Osman, Douglas S. Tyler

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences